Hepatocellular carcinoma/liver cancer

liver
Some patients who undergo selective internal radiotherapy (SIRT) with yttrium-90 (Y-90) may be eligible for liver resection, researchers reported. SIRT is typically a palliative procedure, but certain patients have a response that warrants surgical resection with curative intent. To better… Read More
liver
Liver resection may lead to better outcomes than transarterial chemoembolization (TACE) for cirrhotic patients with resectable intermediate-stage hepatocellular carcinoma (HCC), according to a study published in Cancer Medicine. Although TACE is typically recommended for intermediate-stage HCC,… Read More
liver
A combined microsphere sizing strategy seemed technically feasible and had a promising toxicity profile and effectiveness measures, researchers reported. The study was prospective, single-center, and had a single arm consisting of 36 consecutive patients with hepatocellular carcinoma (HCC) who had… Read More
Lewandowski
Radiation lobectomy is an evolving technique that offers an alternative to portal vein embolization for patients who are not surgical candidates as a result of insufficient future liver remnant. In this interview, Robert Lewandowski, MD, an interventional radiologist and Director of Interventional… Read More
liver
Researchers have developed a prognostic score that can help to stratify candidates for transarterial chemoembolization (TACE), according to a study published in the Journal of Hepatology. “There lacks a prognostic model specifically developed for recommended or ideal TACE candidates with HCC (BCLC… Read More
liver
Patients with hepatocellular carcinoma (HCC) and gross vascular invasion (GVI) may have improved overall survival (OS) after being treated with dual modality radiation with external beam radiation therapy (EBRT) and transarterial radioembolization (TARE). Researchers reported their findings in the… Read More
liver
Results of a phase II trial suggest that image-guided high-dose-rate (HDR) brachytherapy (iBT) may lead to better outcomes than conventional transarterial embolization (cTACE) in treating unresectable hepatocellular carcinoma (HCC). The authors were interested in exploring the value of iBT in… Read More
liver
Transcatheter arterial chemoembolization (TACE) combined with apatinib (TACE-apatinib) prolonged time to progression (TTP) and overall survival (OS) compared to TACE-alone for Barcelona Clinic Liver Cancer (BCLC) stage C HCC, according to a study published in BMC Cancer. This retrospective study… Read More
HCC cells
No significant difference in overall survival (OS) and liver cancer-specific survival (LCSS) was found in patients with localized hepatocellular carcinoma (HCC) treated with either cryoablation (cryo) or radiofrequency ablation (RFA), according to a study published in Anticancer Research. This… Read More
HCC cells
A new study that looked at outcomes of surgical resection after yttrium-90 (Y90) transarterial radioembolization (TARE) in patients with hepatocellular carcinoma found that TARE can serve as a safe bridge to resection. The results were published in the Journal of Vascular and Interventional… Read More